Nov 29, 2016 12:16PM Streetinsider.com's Hot Lunchtime Reads 11/29: (FB) (TIF) (VBLT) (LLL)

Nov 29, 2016 11:42AM Roth Capital Affirms Vascular Biogenics (VBLT) at 'Buy' Following Topline VB-111 Phase 2 Data

Aug 15, 2016 12:20PM Roth Capital Keeps VBL Therapeutics (VBLT) at 'Buy' Following Q2 Results; Glioblastoma Remains in Focus

Jun 6, 2016 02:16PM VBL Therapeutics' (VBLT) ASCO Data Emphasizes VB-111's Potential in Multiple Tumors - Roth Capital

Nov 13, 2015 02:04PM Roth Reaffirms VBL Therapeutics (VBLT) at 'Buy'; Financing Overhang Removed, Partnership Now Key Focus

Nov 6, 2015 09:13AM Vascular Biogenics Ltd. Announces Closing of $15 Million Underwritten Offering of Ordinary Shares and Warrants

Nov 3, 2015 09:26AM VBL Therapeutics (VBLT) Prices $15M Offering of Ordinary Shares and Warrants

Nov 3, 2015 09:21AM Vascular Biogenics Ltd. Announces Pricing of $15 Million Underwritten Offering of Ordinary Shares and Warrants

Nov 3, 2015 09:21AM Vascular Biogenics Ltd. Announces Pricing of $15 Million Underwritten Offering of Ordinary Shares and Warrants

Sep 28, 2015 08:50AM Roth Capital Raised Price Target on VBL Therapeutics (VBLT) Following ASCO Showing

Aug 20, 2015 09:44AM Roth Remains Positive on VBL Therapeutics (VBLT) as VB-111 Phase 3 in rGBM Commences

Jun 1, 2015 02:14PM Roth Affirms Vascular Biogenics (VBLT) at 'Buy' Following VB-111 in rGBM Update; Phase 3 Study is 'Well Designed'

May 26, 2015 12:58PM Unusual 11 Mid-Day Movers 5/26: (GKNT) (ATNM) (FXCM) Higher; (CYRN) (JMEI) (GMAN) Lower

May 22, 2015 10:25AM Notable Analyst Rating Changes 5/22: (RWLK) (BAH) (DOV) Upgraded; (GD) (JGW) (CONN) Downgraded

May 22, 2015 06:21AM Roth Capital Starts Vascular Biogenics Ltd (VBLT) at Buy